“FasL-microgels induce immune acceptance of islet allografts in nonhuman primates.”
3 institutional releases
Published in Science Advances · View the paper (DOI)
A new biomaterial-based technique has improved islet transplants for type 1 diabetes treatment by inducing permanent immune acceptance. The microgels educate the immune system to accept the graft, making it possible to regulate blood glucose levels without chronic immunosuppression.
Coverage from 3 institutions
- Biomaterial improves islet transplants for treatment of type 1 diabetes Georgia Institute of Technology · May 13, 2022 · first to report
- Modifying the body’s immune system to help treat Type 1 diabetes University of Missouri-Columbia · May 13, 2022
- Novel biomaterial prevents rejection of transplants for type 1 diabetes Massachusetts General Hospital · May 13, 2022